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Abstract
The inflammasome is a complex of proteins that plays a critical role in mounting an inflammatory 
response in reply to a harmful stimulus that compromises the homeostatic state of the tissue. The 
NLRP3 inflammasome, which is found in a wound-like environment, is comprised of three 
components: the NLRP3, the adaptor protein ASC and caspase-1. Interestingly, while ASC levels 
do not fluctuate, caspase-1 levels are elevated in both physiological and pathological conditions. 
Despite the observation that merely raising caspase-1 levels is sufficient to induce inflammation, 
the crucial question regarding the mechanism governing its expression is unexplored. We find that 
in an inflammatory microenvironment, caspase-1 is regulated by NFκB. Consistent with this 
association, the inhibition of caspase-1 activity parallels the effects on wound-healing caused by 
the abrogation of NFκB activation. Surprisingly, not only does inhibition of the NFκB/caspase-1 
axis disrupt the inflammatory phase of the wound-healing program, it also impairs the stimulation 
of cutaneous epithelial stem cells of the proliferative phase. These data provide a mechanistic 
basis for the complex interplay between different phases of the wound-healing response in which 
the downstream signaling activity of immune cells can kindle the amplification of local stem cells 
to advance tissue repair.
Introduction
The major function of the skin is to provide a physical barrier between the body and the 
external environment. Consequently, it is frequently damaged and mounts a complex 
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wound-healing program to restore tissue homeostasis. This wound-healing response is 
organized into three interdependent phases: an inflammatory phase leading to the 
recruitment and activation of immune cells; a proliferative phase comprising the expansion 
of the progenitor cell pool, angiogenesis and re-epithelialization (migration of keratinocytes 
to close the wound); and the remodeling phase wherein alterations in tissue architecture and 
the extracellular matrix is carried out (Gurtner et al., 2008). Hindering the mechanistic 
understanding of this process is the fact that signaling by cells in one phase of the wound-
healing program impact the behavior of cells associated with another phase.
In response to many different external stimuli, inflammation can be mediated by a 
multiprotein complex known as an inflammasome, which promotes the maturation and 
secretion of proinflammatory cytokines. The inflammasome can be comprised of an NLR 
(nucleotide-binding domain and leucine-rich repeat containing) protein, an adaptor protein 
ASC (apoptosis-associated speck-like protein) and pro-caspase-1. The NLR proteins are a 
family of intracellular sensors that can detect the presence of pathogens and also recognize 
danger or stress signals (Schroder and Tschopp, 2010). Whereas the levels of the adaptor 
protein Asc remains unchanged, we found that the stress kinase p38 MAPK is responsible 
for the upregulation of NLRP3 in a wound-like environment (Lee et al., 2009), but the 
regulation of caspase-1 expression remains poorly understood.
Caspase-1 is a cysteine protease that is synthesized as a zymogen. The assembly of NRLP3 
inflammasome induces the cleavage and activation of procaspase-1 which can then process 
interleukin-1 (IL-1) family members such as IL-1α (Keller et al., 2008), IL-1β and IL-18 
into their mature forms (Yu and Finlay, 2008). In the context of wounding (Lee et al., 2009) 
as well as diseases with chronic inflammation such as psoriasis (Johansen et al., 2007) heart 
disease (Merkle et al., 2007), gout and arthritis (Church et al., 2008), there is an 
upregulation of procaspase-1 expression. Despite these observations, both the mechanism 
and the functional relevance of increasing the expression of procaspase-1 has failed to 
garner much attention. A clue to the importance of the upregulation of procaspase-1 was the 
development of cutaneous inflammation simply by overexpressing pro-caspase-1 in 
epidermal keratinocytes (Yamanaka et al., 2000).
A prime candidate for the transcriptional regulator of caspase-1 is the transcription factor 
nuclear factor-kappa B (NFκB), a well-known mediator of the inflammatory response 
(Karin, 2009). This dimeric complex is sequestered in the cytosol via its association with 
IκB. Activation of NFκB is accomplished through the IκB kinase (IKK), which can 
phosphorylate IκB and lead to its dissociation from NFκB. Upon activation, NFκB dimers 
are translocated into the nucleus where they modulate the expression of numerous genes 
involved in the immune response. To investigate the potential link between NFκB and 
caspase-1 in restoring tissue homeostasis, we exploited the conditional deletion of epidermal 
caspase-8 (C8cKO) as a model of wound-healing and in which caspase-1 levels are elevated 
throughout the epidermis (Lee et al., 2009).
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Results
The expression of caspase-1 is regulated by NFκB
To test the hypothesis that NFκB regulates procaspase-1 expression, epidermal explants 
from wild-type and caspase-8 conditional knockout (C8KO) mice were treated with DMSO 
(vehicle control) or a pharmacological inhibitor of NFκB activation. Inhibition of NFκB 
activation was accomplished with a chemical inhibitor of the upstream activator of NFκB 
(IKK inhibitor [IKK-I]). In the C8KO epidermis, the increased procaspase-1 is diminished 
to near wild type levels with the treatment with IKK-I at both the RNA (Figure 1A) and 
protein level. This effect is both dose-dependent (Supplementary Figure 1) and reversible 
(Figure 1A). Interestingly, IKK-I did not affect the expression of NLRP3 despite 
suggestions to the contrary (Bauernfeind et al., 2009) (Figure 1B). On the other hand, p38 
MAPK regulates NLRP3 in the wound-like epidermis (Figure 1B), but did not affect the 
increase in procaspase-1 (Figure 1A). The third component of many NLRP3-containing 
inflammasomes is Asc, whose levels were constant in wild type and C8KO epidermis 
(Figure 1C). Altogether, these inhibitor studies suggest that expression of the components of 
the NLRP3 inflammasome is under the regulation of at least two convergent signaling 
pathways – p38 MAPK regulates NLRP3 expression, while NFκB controls the expression of 
procaspase-1.
In order to examine whether NFκB activity is sufficient to induce procaspase-1, we utilized 
newborn epidermal explants lacking Iκbα, a negative regulator of NFκB. The basal level of 
NFκB activity in wild-type and Iκbα knockout mice are the same, but there is a prolonged 
activation of NFκB signaling with a pulse of a stimulus such as IL-1 or TNF in iκbα null 
cells (Klement et al., 1996). A ∼13-fold increase in the level of a bona fide NFκB target 
gene, RANTES, verified that the loss of Iκbα induces an extended activation of NFκB 
signaling in epidermal explants (Supplementary Figure 2). Under these conditions, 
procaspase-1 expression remains ∼70 fold higher in the Iκbα knockout epidermis relative to 
the wild type control (Figure 1D) but there is no appreciable effect on NLRP3 or Asc (data 
not shown). Interestingly, despite the ∼70 fold increase in caspase-1 RNA levels in the iκbα 
KO relative to the wild type control, the increase of caspase-8 protein level, though 
significant, was only ∼4 fold. Secreted IL-1α is not only the product of caspase-1 activity 
but is also involved in a positive feedback loop to activate NFκB in an autocrine or 
paracrine fashion (Vallabhapurapu and Karin, 2009). In order to determine how much of the 
increase in caspase-1 expression is due to this positive feedback loop we tested the effect of 
blocking the signaling of IL-1α with a neutralizing antibody. Neutralizing extracellular 
IL-1α dramatically reduces the induction of procaspase-1 expression in the iκbα null 
background (Figure 1D). The remaining ∼15 fold increase in caspase-1 levels in the iκbα 
knockout epidermis may reflect the direct intracellular signaling events linking NFκB to 
caspase-1. This theory was substantiated by the effect of the caspase-1 inhibitor, which 
would effectively short circuit the positive feedback loop resulting from the caspase-1 
dependent secretion of IL-1α. The treatment of iκbα null epidermis with the caspase-1 
inhibitor likewise results in a ∼15-fold difference in caspase-1 RNA levels compared to the 
wild type explants (Figure 1D). The decrease in caspase-1 expression by the IL-1α inhibitor 
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antibody or the caspase-1 inhibitor in the iκbα KO skin is also reflected at the protein level 
(Figure 1D).
Reconstitution of caspase-1 regulatory control in vitro
In contrast to the heterogeneous population of cells that comprise the epidermis used above, 
we investigated whether the NFκB-caspase-1 relationship is valid within wounded 
epidermal keratinocytes in vitro. 16 hours after applying a scratch wound on a confluent 
sheet of keratinocytes, a decrease in caspase-8 protein levels was only observed in cells 
migrating from the wound edge (Figure 2A). This occurred in tandem with the activation of 
NFκB (Figure 2B and Supplementary Figure 3A). Consistent with our proposed pathway, 
the decrease in caspase-8 in epidermal keratinocytes leading to the activation of NFκB 
resulted in an increase in caspase-1 expression (Figure 2C and Supplementary Figure 3B). 
Interestingly, the increased in caspase-1 protein levels was observed in both the cytosol and 
nucleus of the migrating cells (Supplementary Figure 3C and D). This nuclear translocation 
of caspase-1 has previously been described upon exposure of cells to TNF(Mao et al., 1998) 
though the function remains unknown. We then examined whether activation of NFκB is 
sufficient to induce caspase-1 expression in vitro by transfecting primary keratinocytes with 
a constitutively active mutant of IKK2 (IKK2-CA). Twelve hours after transfection, about 
10% of the cultured cells expressed the IKK2-CA construct leading to the activation of 
NFκB (Figure 2D and Supplementary Figure 3E) and a ∼2.5 fold increase in caspase-1 
RNA (Figure 2E) and protein (Supplementary Figure 3F) expression. Moreover, activation 
of NFκB with IL-1α can elevate the amount of procaspase-1 protein, and this effect can be 
blocked by inhibiting NFκB activation with the IKK inhibitor or with glyburide, which 
blocks inflammasome function (Figure 2F, Supplementary Figure 3G).
These results provide evidence that NFκB is involved in the regulation of caspase-1 
expression, but it is unclear whether NFκB is the direct upstream transcriptional activator. 
To address this question, we cloned a 1kb fragment of the proximal promoter of caspase-1, 
which contains a conserved NFκB binding motif (Supplementary Figure 4A), and found that 
mutating this consensus sequence significantly reduced the ability of active NFκB to induce 
caspase-1 transcription (Supplementary Figure 4B). Moreover, we tested whether this 
likewise occurs on the conserved motif on the endogenous caspase-1 promoter in primary 
keratinocytes via chromatin immunoprecipitation. After a 4-hour stimulation with IL-1α 
(Supplementary Figure 4C), we were able to co-precipitate the NFκB binding motif of the 
caspase-1 promoter with the p65 subunit of the NFκB complex (Figure 2G), suggesting that 
this transcription factor is a direct activator of caspase-1 expression.
Caspase-1 amplifies NFκB signaling in the epidermis
Upon establishing the NFκB/caspase-1 regulatory relationship in vitro, we then focused our 
attention on its regulation and function within a tissue. We incubated wild type or C8KO 
epidermal explants in media with vehicle control (DMSO) or IKK inhibitor and assayed for 
the amount of secreted IL-1, which is a read-out for activated caspase-1. We previously 
found that the levels of IL-`α in the C8KO skin is higher than wild type, but its secretion 
was still dependent on caspase-1 activity (Lee et al., 2009). Reducing caspase-1 expression 
in the C8KO epidermis through the inhibition of NFκB also reduces the secretion of IL-1α 
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to wild type levels (Figure 3A). This occurs concomitant with a blockage of proteolytic 
cleavage of caspase-1 into its active p20 fragment (Supplementary Figure 5A). Furthermore, 
we observed that the prolonged activity of NFκB in the IκBα deficient epidermis results in 
the higher expression of procaspase-1 (Figure 1D), prompting us to examine whether this 
likewise translates into an increase in IL-1α secretion. The prolonged NFκB signaling in the 
IκBα KO resulted in a substantial increase activated caspase-1 (Supplementary Figure 5B) 
and in IL-1α secretion (Figure 3B) compared to the wild type epidermis. Reducing the 
activity of caspase-1 in the IκBα knockout epidermis (Supplementary Figure 5B) 
dramatically reduced the amount of secreted IL-1α (Figure 3B). This effect of activated 
NFκB on raising IL-1α secretion can be reconstituted in vitro by transfecting keratinocytes 
with the IKK2-CA construct (Figure 3C). Moreover, pharmacological inhibition of 
caspase-1 activity can also abrogate the stimulation of IL-1α secretion. The secretion of 
IL-1α has been shown to be dependent upon caspase-1 activity (Keller et al., 2008), and the 
NFkB-caspase-1 signaling pathway also yields similar results when tested on the 
intracellular levels of IL-1α (Supplementary Figure 5C-F) as well as the secretion of IL-1β, 
a classical readout of caspase-1 function (Supplementary Figure 5G-I).
The ability of IL-1α ligand to activate NFκB suggests that the release of this cytokine can 
propagate the NFκB-caspase-1-IL-1α module throughout the epidermis via a paracrine 
effect. We found that removal of the IL-1 receptor in the wound model diminished the level 
of secreted IL-1α compared to the C8cKO epidermis (Figure 3D). We further tested this 
paracrine model by transfecting primary keratinocytes with the constitutively active IKK 
mutant construct (IKK2-CA). As we have shown, keratinocytes expressing IKK2-CA 
displayed nuclear NFκB twelve hours after transfection (Figure 2D). However, when we 
allowed the cells to incubate longer (∼24 hours), cells adjacent to the transfected cells were 
induced to activate NFκB (Figure 3E). Use of the IL-1α neutralizing antibody or the 
caspase-1 inhibitor restricted NFκB activation solely to cells transfected with IKK2-CA.
To test whether this is also valid in wound-like conditions in vivo, we subcutaneously 
injected vehicle control (DMSO), or IKK inhibitor daily in the back skin of newborn wild 
type or C8cKO mice for four days. Inhibition of NFκB activation, which blocks IL-1α 
release (Figure 3A), suppresses the expression of active NFκB throughout the epidermis, 
though the dermal activation of NFκB is largely unaffected (Figure 4A). This block in 
epidermal activation of NFκB was also present when excisional wounds were treated with 
IKK inhibitor (Supplementary Figure 6). Moreover, genetic removal of caspase-1 expression 
from the C8cKO epidermis (Figure 4B-C) likewise reduces the expression of active NFκB 
throughout the epidermis.
Since the inhibition of NFκB activity and caspase-1 expression both prevented the spreading 
of active NFκB in the C8cKO epidermis, we predicted that the expression of caspase-1 
would likewise be adversely affected. Caspase-1 is expressed at a low basal level in wild 
type epidermis, is significantly upregulated in the C8cKO tissue, and this induction is lost in 
the presence of IKK-I (Figure 4D). Interestingly, application of a pharmacological inhibitor 
of caspase-1 activity (C1-I) results in a dramatic reduction in the expression of caspase-1 
throughout the tissue and the remaining protein is restricted to the upper layers of the 
epidermis (Figure 4D). Moreover, in the absence of IL-1 signaling, caspase-1 expression is 
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not highly induced in the C8cKO epidermis (Figure 4E). Therefore, abrogation of NFκB 
activation inhibits the upregulation of caspase-1 expression and inhibition of the latter's 
proteolytic activity can effectively block the spreading of NFκB and caspase-1 expression 
from the surface of the epidermis to the lower layers of this tissue, which occurs through 
IL-1 paracrine signaling.
Inhibition of NFκB and caspase-1 delays wound closure rates
We then focused our attention on the functional contribution of these proteins to the wound 
healing response. Excisional wounds were made on the back of wild type mice treated with 
DMSO or IKK-I, caspase-1 knockout mice and IL-1R KO mice (Figure 5). Interestingly, 
inhibition of NFκB activation or caspase-1 expression significantly delayed the closure rate 
of an excisional wound compared to control samples (Figure 5A). This delay in wound 
closure by 2 or more days parallels the effects seen when other important factors for wound 
healing are deleted (Devalaraja et al., 2000; Echtermeyer et al., 2001; Jameson et al., 2002). 
We verified that both the inhibition of NFκB activation and caspase-1 expression indeed 
impacted inflammation as they were able to decrease the recruitment of immune cells to the 
skin. For instance, the number of macrophages and T-cells recruited to the skin in the 
C8cKO (Figure 5 B and C) or to wounded skin (Supplementary Figure 7 A and B) is 
severely reduced when NFκB activity or caspase-1 expression is suppressed. The failure to 
recruit immune cells to the skin under these conditions is also reflected in the diminished 
expression of inflammatory genes (Figure 5D). Together these data highlight the critical role 
for the NFκB/caspase-1/IL-1 axis in the establishment of the inflammatory phase of the 
cutaneous wound healing response.
NFκB/Caspase-1 signaling affects proliferation during the wound healing response
Closer examination of the effects of the NFκB and caspase-1 inhibition on the rate of wound 
closure reveals an affect during the proliferative phase of the wound response, which 
commences around day three post-wounding. This effect may be attributable to the role that 
NFκB and caspase-1 play in the secretion of IL-1. We previously demonstrated the IL-1 
mediated epithelial-mesenchymal signaling loop that stimulates keratinocytes proliferation 
in a wound is recapitulated in the C8cKO model (Lee et al., 2009). One outcome of this pro-
proliferation signaling network is the thickening of the epidermis (epidermal hyperplasia).
Consistent with this model, inhibition of NFκB activation or loss of caspase-1 expression in 
the C8cKO skin significantly reduced epidermal hyperplasia (Figure 6A and Supplementary 
Figure 8A). This phenomenon was also seen in response to excisional wounds 
(Supplementary Figure 8B). The thickening of the epidermis in the C8cKO mouse is fueled 
by an increase in the number of proliferating progenitor cells found in the basal layer of the 
epidermis and the hair follicle (Figure 6B). Both are reduced in the presence of the inhibitor 
of NFκB activation or loss of caspase-1 expression (Figure 6B-D). However, these effects 
are not applicable to all the phenomena associated with the proliferative phase of the wound 
healing response. For instance, new blood vessel formation is a feature of this phase of the 
wound-healing program, but the injection of IKK inhibitor or the loss of caspase-1 
expression do not qualitatively decrease angiogenesis in the skin (Figure 6E). Altogether, 
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these observations link a functional inflammatory phase of the wound healing response with 
the optimal stimulation of cell proliferation that occurs during a wound healing response.
Discussion
A major obstacle to understanding wound healing is the untangling of the extensive 
interdependence of the three classical phases of this process. Using the ablation of epidermal 
caspase-8 as a model of wound healing, we have uncovered a molecular mechanism 
synchronizing these complex reactions. Upon wounding, caspase-8, which normally resides 
in the granular layer near the surface of the epidermis is downregulated and initiates a 
biochemical program to promote tissue repair (Lee et al., 2009). One effect of this 
downregulation is the increase in IL-1α RNA expression as well as the release of the 
preexisting reservoir of this cytokine from epidermal keratinocytes (Lee et al., 2009). IL-1α 
has a plethora of effects ranging from the promotion of an inflammatory microenvironment 
to promoting a growth arrest and survival model in suprabasal keratinocytes to the 
stimulation of stem cell proliferation. Given the profound impact of IL-1α signaling in the 
framework of wound healing, the mechanism governing its release is an important issue to 
resolve. We found that at least two different signaling pathways impact the components of 
the NLRP3 inflammasome – p38 MAPK regulates NLRP3 expression (Lee et al., 2009) and 
NFκB influences caspase-1 expression levels (Supplementary Figure 9). Together these 
pathways lead to IL-1α secretion that can operate in an autocrine fashion to potentiate the 
NFκB signaling cascade or function in a paracrine manner to propagate NFκB signaling to 
different layers of keratinocytes in the epidermis. This exemplifies the central and complex 
role that IL-1α and NFκB play in regulating epithelial homeostasis (Swamy et al., 2010).
Recently, however, work from David Wallach's group has raised doubts about the role of 
IL-1α in mediating inflammation in the epidermal caspase-8 conditional knockout mouse 
(Kovalenko et al., 2009). This is based on their finding that genetic ablation of both IL-1α 
and IL-1β did not abrogate the cutaneous inflammation stimulated by the loss of epidermal 
caspase-8. However, as we observed, removal of one signaling pathway such as IL-1 can 
delay the kinetics of wound closure but not completely abrogate it. The ≥ 2 day delay in 
wound healing by blocking components of the NFκB/caspase-1/IL-1 axis is consistent with 
the delay in wound-healing found when other important components are deleted such as γδ 
T-cells (Jameson et al., 2002), syndecan-4 (Echtermeyer et al., 2001), and CXCR2 
(Devalaraja et al., 2000). We also observed that the C8cKO/IL1 receptor double knockout 
transiently dampens the phenotype of the C8cKO mouse, which is likely due to the fact that 
other components in the inflammatory phase can compensate for the loss of one constituent. 
Further support for IL-1 signaling in a wound-like environment is provided by the finding of 
increased nuclear NFkB when the IL-1 receptor antagonist is missing (Ishida et al., 2006). 
Thus we propose that the large reservoir of IL-1α released from damaged keratinocytes, is 
amongst the earliest responders to epidermal trauma to stimulate the wound healing 
response. In particular, IL-1α can induce the inflammatory phase and thereby promote the 
proliferative phase and this role is assumed by infiltrating immune cells, which secretes the 
more potent IL-1β.
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An important question that arises from our model is the link between the downregulation of 
caspase-8 and the activation of NFκB prior to the positive feedback loop mediated by IL-1α 
secretion. Of particular relevance are reports that deletion of RIP3 rescues the caspase-8 
knockout phenotype, including cutaneous inflammation (Gunther et al., 2011; Kaiser et al., 
2011; Welz et al., 2011). Interestingly, more recent studies have demonstrated that RIP3 can 
also activate NLRP3 and caspase-1 (Kang et al., 2013; Vince et al., 2012). Thus, the loss of 
caspase-8 may liberate RIP3 to interact with different partners to stimulate inflammasome 
activation. Further delineating the details of inflammasome activation will contribute 
important new insights on how to combat inflammatory diseases when these signaling 
pathways are perturbed.
Materials and Methods
Reagents
The list of antibodies, inhibitors and primers and their usage are detailed in the 
Supplementary information section.
Mice and cell/tissue culture
Generation of C8KO (Lee et al., 2009) and iκbα KO (Klement et al., 1996) mice have 
previously been reported. Wild-type primary mouse keratinocytes are obtained from the 
epidermis of newborn pups and cultured in low-calcium mouse keratinocyte media as 
described previously (Lee et al., 2009). Epidermal explants were taken from P0-P3 skin by 
chemically dissociating it from the dermis with dispase for 1 hour at 37°C. All animal work 
was carried out in accordance with the policies and approved procedures of the Institutional 
Animal Care and Use Committee of UC San Diego.
Tissue preparation
Epidermal explants were incubated with p38-I and IKK-I overnight and collected in Trizol 
(Invitrogen) for RNA extraction or in sample buffer for protein extraction. The wash-out of 
IKK-I treated epidermis was done by washing with PBS once and transferred to fresh mouse 
keratinocyte media and incubated for another 6 hours. Glyburide was incubated with the 
epidermis for 1 hour, and transferred to fresh media with glyburide for another hour. IL-1α 
(2 ng/ul) was added to WT and iκbα KO epidermis for 2 hours, and replaced with fresh 
media and incubated for another 6 hours prior to sample collection.
Wounding and injection of mice
DMSO, IKK-I, and C1-I were injected to the back skin of WT and caspase 8 KO daily for 4 
days starting at P0 prior to the onset of the phenotype, and back skin were harvested at the 
5th day for RNA extraction and OCT embedding. In vivo wounding was performed on the 
back skin of adult WT mice with 5mm-punch biopsy, and DMSO and inhibitors were 
applied to the wound site daily for 3 days. Wounded skin was collected for RNA extraction 
and OCT embedding. Data presented are averages of 2 wound per mouse (n=6 mice) +/- 
SEM for each treatment. For in vitro scratch wounds, primary mouse keratinocytes were 
cultured on coverslips to confluency. The scratch wound was performed on the cell 
Lee et al. Page 8
J Invest Dermatol. Author manuscript; available in PMC 2016 February 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
monolayer with a p200 pipet tip. Cells were incubated at 37°C for up to 16 hours and then 
fixed for immunofluorescence or harvested for RNA extraction.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. NFκB regulates caspase-1 expression
Epidermal explants from wild type (WT) and caspase-8 KO (C8 KO) were treated with 
DMSO, or inhibitors for p38 MAPK (p38-I) or IKK (IKK-I) and qPCR and Western blots 
were performed for (A) caspase-1, (B) NLRP3, and (C) Asc expression. WO = inhibitor 
washed-out. (D) qPCR of caspase-1 expression in epidermis of newborn wild type or iκbα 
knockout mice treated with DMSO, IL-lα inhibitory antibody (IL-1α inhi. Ab), or caspase-1 
inhibitor (C1-I). For all experiments n=5 biological replicates and each sample was run in 
triplicate for qPCR; error bars are SEM, * denotes p<.001, and ** denotes p<.00001. β-
tubulin level was used as a loading control for Western blots.
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Figure 2. Regulation of caspase-1 by NFκB in wounded cells
(A) Immunofluorescence of (A) caspase-8 (red), DAPI (blue) and (B) NFκB (green) in 
primary keratinocytes after 8 or 16 hours of applying a scratch wound (dotted line denotes 
wound margin). Right panels in (B) are the magnified views of the boxed areas in the left 
panels. (C) qPCR of caspase-1 RNA levels at 0 and 16 hours after applying scratch wound. 
(D) Primary keratinocytes were transfected with constitutively active HA-tagged IKK2 
(IKK2-CA) and stained for active IKK2 (red) and NFκB (green) or caspase-1 (green). Cells 
expressing IKK2 have nuclear NFκB and higher levels of caspase-1. (E) qPCR of relative 
levels of caspase-1 RNA in keratinocytes transfected with empty vector (Con; normalized to 
1) or IKK2-CA. (F) Relative caspase-1 protein levels in keratinocytes exposed to IL-1 and 
DMSO, IKK-I, or glyburide. Caspase-1 protein levels in cells without IL-1α stimulation is 
normalized to 1 and data are presented as fold difference. Data is the mean of 3 biological 
replicates and error bars are SEM. (G) ChIP of NFκB upon stimulation with IL-1α and 
immunoprecipitation with IgG control antibody or an antibody recognizing the p65 subunit 
of NFκB. * = p<.001. For qPCR experiments (C & E), results are from 3 biological 
replicates with each PCR reaction performed in triplicate (error bars are SEM).
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Figure 3. Caspase-1 propagates NFκB signaling in epidermal keratinocytes
Secretion of IL-1α was measured by ELISA from different samples: (A) Wild type [orange 
bars] or caspase-8 null (C8KO) [blue bars] epidermis treated with DMSO or IKK-I; (B) wild 
type or iκbα null [purple bars] epidermis treated with DMSO or C1-I; (C) primary 
keratinocytes transfected with empty vector (control), IKK2-CA, or IKK2 CA and treated 
with C1-I; (D) epidermis from wild type, caspase-8 null, and caspase-8/IL-1R double 
knockout mice. ELISA results are the mean of 3 biological replicates and error bars are 
SEM. * denotes p<.001, and ** denotes p<.00001. (E) Primary keratinocytes were 
transfected with constitutively active IKK2 (HA-IKK2-CA) and treated with DMSO 
(control), IL-1α inhibitory antibody, or caspase-1 inhibitor (C1-I) and stained for IKK2-CA 
(red) and NFκB (green). Data is representative of 3 independent experiments.
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Figure 4. Caspase-1 expands NFκB activity throughout the epidermis
Immunohistochemistry of phosphorylated NFκB in (A) wild type and caspase-8 knockout 
skin injected with DMSO or IKK-I, and (B) in skin lacking both caspase-8/caspase-1 
(C8/C1 dKO) or skin that are null for caspase-8 and IL-1 receptor (C8/IL-1R dKO). (C) 
Level of phosphorylated NFκB, with total NFκB as loading control. (D) Caspase-1 
expression in wild type or C8KO epidermis treated with vehicle control or chemical 
inhibitors. (E) Caspase-1 expression in wild type, caspase-8 null and caspase-8/IL-1R 
double knockout skin samples.
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Figure 5. Effect of NFκB and caspase-1 on wound closure
(A) Rates of wound closure were measured in wild type mice treated daily with DMSO or 
IKK-I, or in mutant mice lacking either caspase-1 (C1KO) or IL-1 receptor (IL-1RKO). 
Data points are averages of 6 mice with two wounds/mouse (* denotes p<.001, and ** 
denotes p<.00001 when comparing DMSO vs. IKK-I kinetics in wild type mice). (B) 
Recruitment of macrophages (green) in the wild type and caspase-8 null skin treated with 
DMSO (control) or IKK-I or in skin lacking caspase-1 and -8. (C) Recruitment of T-cells 
(green) monitored using the pan T cell marker CD3. The epidermis (epi) and hair follicles 
(hf) in B & C are noted in red with an antibody detecting keratin-5. Scale bar: 50 μm; der = 
dermis (D) Inflammatory gene expression in the wounded/wound-like skin. RNA was 
extracted from the wounded skin of wild type mice (treated with DMSO [orange bars] or 
IKK-I [yellow bars]) or caspase-1 KO mice (C1KO; red bars) 3 days post excisional 
wounding. RNA was also extracted from the skin of P5 caspase-8 knockout (C8KO) mice 
(treated with DMSO [blue] or IKK-I [light blue]) or the caspase-8/caspase-1 (C1KO) double 
knockout mouse [magenta]. Results are from 3 biological replicates for each mouse 
genotype/treatment and each sample was repeated in triplicate. Error bars are SEM.
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Figure 6. Hyperproliferation of the epidermis in caspase-8 KO and wounded skin
(A) Measurement of epidermal thickness of wild type (WT) or caspase-8 knockout (KO) 
skin treated with DMSO, or IKK-I, or skin also lacking caspase-1. (B) Proliferating cells 
were marked by Ki67 (green) and the epidermis and hair follicle are marked by keratin 5 
(red) in mice treated as in (A). Scale bar: 50 μm. Quantification of proliferating (C) 
interfollicular epidermal (IFE) stem cells and (D) hair follicle stem cell (HFSC) in skin 
sections from (B). Results are the average of 6 skins (5 sections/skin) for each treatment and 
error bars are SEM, (* denote p<.001). (E) Angiogenesis monitored in wild type or knockout 
mice treated with DMSO, or IKK-I, or skin also lacking caspase-1 via staining with CD31 
(green).
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